EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women

Mika Mizuno, Masaki Kamio, Mika Sakihama, Shintaro Yanazume, Shinichi Togami, Tadao Kakizoe, Hiroaki Kobayashi

Gynecologic and Obstetric Investigation · 2024

DOI: 10.1159/000541641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gynecologic and Obstetric Investigation, 2024. Verfasst von Mika Mizuno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan. Hauptthemen laut MEDLINE: Papillomavirus Infections, Early Detection of Cancer, Uterine Cervical Neoplasms, Papillomaviridae. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The high incidence of invasive cervical cancer among those who have not undergone cancer screening is a serious problem. This study aimed to investigate the utility of human papillomavirus (HPV) test results from self-collected urine and vaginal samples as screening tools.

Design

The study was conducted in two steps. First, the appropriate storage container, temperature, and time until urine HPV assay performance were verified. Second, the results of spot urine testing under those conditions and of gynecologist-collected cervical and self-collected vaginal samples were compared to verify the feasibility of using the BD Onclarity® HPV assay for individuals with abnormal cervical cytology. Participants/Materials, Setting, Methods: The participants were 121 women with abnormal cervical cytology. Self-collected urine and vaginal samples, along with gynecologist-collected cervical samples, were tested for HPV using the BD Onclarity® HPV assay. The optimal conditions for urine sample storage were identified by comparing the HPV detection rates under various conditions.

Results

Urine stored in a BD Probe Tec™ (QxUPT) for less than 72 h at room temperature was found to have the highest HPV positivity rate. Under these conditions, the detection rates of HPV in urine, cervical, and vaginal samples were examined. HPV type 16 was detected in 41.7% of the cervical samples, type 18 in 10%, and types 31 and 52 in 12.6% each. The concordance rate for HPV testing between clinician-collected cervical and urine samples was 63.9% (kappa: 0.34; 95% CI: 0.21–0.47), and that between clinician-collected cervical and self-collected vaginal samples was 77.8% (kappa: 0.68; 95% CI: 0.53–0.83), indicating good concordance. In a population with an HPV-related lesion/tumor prevalence of approximately 70%, the sensitivity of HPV testing was 82.7% for the cervix, 46.4% for urine, and 75.7% for vaginal samples.

Limitations

The primary limitation is the lower detection rate of HPV in spot urine samples than in other sample types, indicating room for methodological improvement. The study’s findings are based on a specific population, which may limit generalizability.

Conclusions

We investigated the optimal self-collected urine-to-testing time and temperature. Self-collected vaginal and urine HPV tests show moderate-high concordance with clinician-collected cervical HPV tests, suggesting their potential utility for women who do not undergo regular cancer screening. However, the sensitivity was not high in spot urine. Therefore, further large-scale studies are needed to verify these findings and optimize testing methods to encourage broader participation in cancer screening programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsEarly Detection of CancerUterine Cervical NeoplasmsPapillomaviridaeHumansFemaleMiddle AgedAdultSpecimen HandlingVaginal SmearsJapanVaginaGenotypeAgedUrine Specimen CollectionUrineHuman Papillomavirus VirusesEast Asian People

Stichwörter der Autor:innen

Cervical cancer screeningCervical intraepithelial neoplasiaOnclarity human papillomavirus assaySelf-samplingUrine human papillomavirusVaginal human papillomavirus

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.
  • Japan Cancer Society, Tokyo, Japan.

Zitieren

APA

Mizuno, M., Kamio, M., Sakihama, M., Yanazume, S., Togami, S., Kakizoe, T., & Kobayashi, H. (2024). The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000541641

Vancouver

Mizuno M, Kamio M, Sakihama M, Yanazume S, Togami S, Kakizoe T, et al. The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women. Gynecologic and Obstetric Investigation. 2024. doi:10.1159/000541641

BibTeX
@article{Mizuno2024,
  author = {Mizuno, Mika and Kamio, Masaki and Sakihama, Mika and Yanazume, Shintaro and Togami, Shinichi and Kakizoe, Tadao and Kobayashi, Hiroaki},
  title = {The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2024},
  doi = {10.1159/000541641}
}
Kostenlos starten →